Conning Inc. Verrica Pharmaceuticals Inc. Transaction History

Conning Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$2.09 - $3.39 $269,637 - $437,354	129,013 New	129,013 $354,000
Q1 2020 Apr 29, 2020	SELL	$7.14 - $16.86 $921,152 - $2.18 Million	-129,013 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$13.94 - $19.88 $23,976 - $34,193	-1,720 Reduced 1.32%	129,013 $2.1 Million
Q2 2018 Jul 25, 2018	BUY	$17.5 - $20.34 $2.29 Million - $2.66 Million	130,733 New	130,733 $2.58 Million

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

Stay updated on Conning Inc. with notifications on news.